Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Clonality of circulating tumor cells in breast cancer brain metastasis patients.

Riebensahm C, Joosse SA, Mohme M, Hanssen A, Matschke J, Goy Y, Witzel I, Lamszus K, Kropidlowski J, Petersen C, Kolb-Kokocinski A, Sauer S, Borgmann K, Glatzel M, Müller V, Westphal M, Riethdorf S, Pantel K, Wikman H.

Breast Cancer Res. 2019 Sep 3;21(1):101. doi: 10.1186/s13058-019-1184-2.

2.

Immunologic Profiling of Mutational and Transcriptional Subgroups in Pediatric and Adult High-Grade Gliomas.

Bockmayr M, Klauschen F, Maire CL, Rutkowski S, Westphal M, Lamszus K, Schüller U, Mohme M.

Cancer Immunol Res. 2019 Sep;7(9):1401-1411. doi: 10.1158/2326-6066.CIR-18-0939. Epub 2019 Jul 2.

PMID:
31266783
3.

EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients.

Scharpenseel H, Hanssen A, Loges S, Mohme M, Bernreuther C, Peine S, Lamszus K, Goy Y, Petersen C, Westphal M, Glatzel M, Riethdorf S, Pantel K, Wikman H.

Sci Rep. 2019 May 15;9(1):7406. doi: 10.1038/s41598-019-43678-6.

4.

Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease.

Hanssen A, Riebensahm C, Mohme M, Joosse SA, Velthaus JL, Berger LA, Bernreuther C, Glatzel M, Loges S, Lamszus K, Westphal M, Riethdorf S, Pantel K, Wikman H.

Cancers (Basel). 2018 Dec 19;10(12). pii: E527. doi: 10.3390/cancers10120527.

5.

Subgroup-specific immune and stromal microenvironment in medulloblastoma.

Bockmayr M, Mohme M, Klauschen F, Winkler B, Budczies J, Rutkowski S, Schüller U.

Oncoimmunology. 2018 May 24;7(9):e1462430. doi: 10.1080/2162402X.2018.1462430. eCollection 2018.

6.

Rate and risk factors for a hyperactivity delirium in patients with aneurysmal subarachnoid haemorrhage.

Sauvigny T, Mohme M, Grensemann J, Dührsen L, Regelsberger J, Kluge S, Schmidt NO, Westphal M, Czorlich P.

Neurosurg Rev. 2019 Jun;42(2):481-488. doi: 10.1007/s10143-018-0990-9. Epub 2018 Jun 9.

PMID:
29948495
7.

Inverse Perfusion Requirements of Supra- and Infratentorial Brain Metastases Formation.

Schneider T, Kemmling A, Schroeder J, Pantel K, Glatzel M, Schoen G, Mohme M, Fiehler J, Gellißen S.

Front Neurol. 2018 May 30;9:391. doi: 10.3389/fneur.2018.00391. eCollection 2018.

8.

Tectal gliomas: assessment of malignant progression, clinical management, and quality of life in a supposedly benign neoplasm.

Mohme M, Fritzsche FS, Mende KC, Matschke J, Löbel U, Kammler G, Westphal M, Emami P, Martens T.

Neurosurg Focus. 2018 Jun;44(6):E15. doi: 10.3171/2018.3.FOCUS1850.

PMID:
29852760
9.

Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes.

Mohme M, Schliffke S, Maire CL, Rünger A, Glau L, Mende KC, Matschke J, Gehbauer C, Akyüz N, Zapf S, Holz M, Schaper M, Martens T, Schmidt NO, Peine S, Westphal M, Binder M, Tolosa E, Lamszus K.

Clin Cancer Res. 2018 Sep 1;24(17):4187-4200. doi: 10.1158/1078-0432.CCR-17-2617. Epub 2018 Feb 14.

10.

Impact of the surgical strategy on the incidence of C5 nerve root palsy in decompressive cervical surgery.

Krätzig T, Mohme M, Mende KC, Eicker SO, Floeth FW.

PLoS One. 2017 Nov 16;12(11):e0188338. doi: 10.1371/journal.pone.0188338. eCollection 2017.

11.

Circulating Tumour Cell Release after Cement Augmentation of Vertebral Metastases.

Mohme M, Riethdorf S, Dreimann M, Werner S, Maire CL, Joosse SA, Bludau F, Mueller V, Neves RPL, Stoecklein NH, Lamszus K, Westphal M, Pantel K, Wikman H, Eicker SO.

Sci Rep. 2017 Aug 3;7(1):7196. doi: 10.1038/s41598-017-07649-z.

12.

Cervical vertebroplasty for osteolytic metastases as a minimally invasive therapeutic option in oncological surgery: outcome in 14 cases.

Stangenberg M, Viezens L, Eicker SO, Mohme M, Mende KC, Dreimann M.

Neurosurg Focus. 2017 Aug;43(2):E3. doi: 10.3171/2017.5.FOCUS17175.

PMID:
28760030
13.

Keyhole approaches to intradural pathologies.

Mende KC, Krätzig T, Mohme M, Westphal M, Eicker SO.

Neurosurg Focus. 2017 Aug;43(2):E5. doi: 10.3171/2017.5.FOCUS17198.

PMID:
28760029
14.

Irreversible Total Loss of Brain Function and Organ Donation in Patients with Aneurysmal Subarachnoid Hemorrhage.

Mohme M, Sauvigny T, Grensemann J, Söffker G, Kluge S, Westphal M, Czorlich P.

World Neurosurg. 2017 Sep;105:492-497. doi: 10.1016/j.wneu.2017.06.024. Epub 2017 Jun 12.

PMID:
28619501
15.

Edema is not a reliable diagnostic sign to exclude small brain metastases.

Schneider T, Kuhne JF, Bittrich P, Schroeder J, Magnus T, Mohme M, Grosser M, Schoen G, Fiehler J, Siemonsen S.

PLoS One. 2017 May 11;12(5):e0177217. doi: 10.1371/journal.pone.0177217. eCollection 2017.

16.

Optical Barcoding for Single-Clone Tracking to Study Tumor Heterogeneity.

Mohme M, Maire CL, Riecken K, Zapf S, Aranyossy T, Westphal M, Lamszus K, Fehse B.

Mol Ther. 2017 Mar 1;25(3):621-633. doi: 10.1016/j.ymthe.2016.12.014. Epub 2017 Jan 18.

17.

Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape.

Mohme M, Riethdorf S, Pantel K.

Nat Rev Clin Oncol. 2017 Mar;14(3):155-167. doi: 10.1038/nrclinonc.2016.144. Epub 2016 Sep 20. Review.

PMID:
27644321
18.

Impact of spinal cord compression from intradural and epidural spinal tumors on perioperative symptoms-implications for surgical decision making.

Mohme M, Mende KC, Krätzig T, Plaetke R, Beseoglu K, Hagedorn J, Steiger HJ, Floeth FW, Eicker SO.

Neurosurg Rev. 2017 Jul;40(3):377-387. doi: 10.1007/s10143-016-0790-z. Epub 2016 Oct 7.

PMID:
27714480
19.

Secretory Meningiomas: Increased Prevalence of Seizures Secondary to Edema Formation in a Rare Histologic Subtype.

Mohme M, Emami P, Regelsberger J, Matschke J, Lamszus K, Westphal M, Eicker SO.

World Neurosurg. 2016 Aug;92:418-425. doi: 10.1016/j.wneu.2016.05.046. Epub 2016 May 27.

PMID:
27241088
20.

Secretory Meningiomas: Characteristic Features and Clinical Management of a Unique Subgroup.

Mohme M, Emami P, Matschke J, Regelsberger J, Westphal M, Eicker SO.

Neurosurg Clin N Am. 2016 Apr;27(2):181-7. doi: 10.1016/j.nec.2015.11.001. Epub 2016 Feb 19. Review.

PMID:
27012382
21.

The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma.

Neidert MC, Hostettler IC, Burkhardt JK, Mohme M, Held U, Kofmehl R, Eisele G, Woernle CM, Regli L, Bozinov O.

Neurosurg Rev. 2016 Jul;39(3):401-9. doi: 10.1007/s10143-015-0698-z. Epub 2016 Feb 9.

PMID:
26860420
22.

Initial Clinical Status and Spot Sign Are Associated with Intraoperative Aneurysm Rupture in Patients Undergoing Surgical Clipping for Aneurysmal Subarachnoid Hemorrhage.

Burkhardt JK, Neidert MC, Mohme M, Seifert B, Regli L, Bozinov O.

J Neurol Surg A Cent Eur Neurosurg. 2016 Mar;77(2):130-8. doi: 10.1055/s-0035-1558414. Epub 2015 Jul 27.

PMID:
26216733
23.

Immunological challenges for peptide-based immunotherapy in glioblastoma.

Mohme M, Neidert MC, Regli L, Weller M, Martin R.

Cancer Treat Rev. 2014 Mar;40(2):248-58. doi: 10.1016/j.ctrv.2013.08.008. Epub 2013 Sep 8. Review.

24.

HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis.

Mohme M, Hotz C, Stevanovic S, Binder T, Lee JH, Okoniewski M, Eiermann T, Sospedra M, Rammensee HG, Martin R.

Brain. 2013 Jun;136(Pt 6):1783-98. doi: 10.1093/brain/awt108.

25.

Dry beriberi mimicking Guillain-Barre syndrome as the first presenting sign of thiamine deficiency.

Faigle R, Mohme M, Levy M.

Eur J Neurol. 2012 Feb;19(2):e14-5. doi: 10.1111/j.1468-1331.2011.03602.x. Epub 2011 Dec 5. No abstract available.

PMID:
22136604

Supplemental Content

Support Center